Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia.

Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. Abstract Text:

    jing xueJing Xue,xinsheng biXinsheng Bi,guohao wuGuohao Wu,dan mengDan Meng,jing fangJing Fang,jing xueJing Xue,xinsheng biXinsheng Bi,guohao wuGuohao Wu,dan mengDan Meng,jing fangJing Fang,

    Fludarabine is the major drug against chronic lymphoblastic leukemia. However, the effects of fludarabine on solid tumors remain unclear. We reported previously that fludarabine inhibited expression of hypoxia-inducible factor 1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) in human ovarian cancer cells. The present study aims to investigate, (1) the mechanisms that fludarabine inhibits expression of HIF-1alpha and (2) the effects of fludarabine on tumor cells survival under hypoxia. Human hepatoma HepG2 cells were tested. We found that fludarabine reduced HIF-1alpha stability through prolyl hydroxylation. Fludarabine suppressed hypoxia-induced expression of VEGF and its receptor KDR. It inhibited VEGF-induced activation of AKT and ERK signaling and reduced hypoxia-enhanced HepG2 cell survivability. HepG2 cells were much more sensitive to fludarabine treatment under hypoxia than under nomoxia. These results suggest that fludarabine reduces survivability of HepG2 cells via VEGF signaling under hypoxia.

    Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. Publishing Authors By Initials

    j xueJ Xue,x biX Bi,g wuG Wu,d mengD Meng,j fangJ Fang,j xueJ Xue,x biX Bi,g wuG Wu,d mengD Meng,j fangJ Fang,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Archives of biochemistry and biophysics

    VOLUME: 468

    Page Numbers: 100-6

    Journal Abbreviation: Arch. Biochem. Biophys.

    ISSN: 1096-0384

    DAY: 25

    MONTH: 09

    YEAR: 2007

    Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372430

    Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia.

    AFFILIATION: The Institute for Nutritional Sciences, Shanghai Institute for Biological Sciences, Graduate School of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Arch Biochem Biophys

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News